APA (7th ed.) Citation

FAL, B., LCL, d. J., TF, d. S., VL, B., J, L., ND, C., . . . V, A. (2022). Lactobacillus delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway. Frontiers in microbiology, 13, 858036. https://doi.org/10.3389/fmicb.2022.858036

Chicago Style (17th ed.) Citation

FAL, Barroso, et al. "Lactobacillus Delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway." Frontiers in Microbiology 13 (2022): 858036. https://doi.org/10.3389/fmicb.2022.858036.

MLA (9th ed.) Citation

FAL, Barroso, et al. "Lactobacillus Delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway." Frontiers in Microbiology, vol. 13, 2022, p. 858036, https://doi.org/10.3389/fmicb.2022.858036.